[1]CurrentPatentAssignee:SORRENTOTHERAPEUTICSINC-US2017/281758,2017,A1Locationinpatent:Paragraph0070;0071
Title: A total synthesis trilogy: calicheamicin γ1(I), Taxol®, and brevetoxin A.
Journal: Chemical record (New York, N.Y.) 20120801
Title: A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia.
Journal: Journal of cell science 20110601
Title: Calicheamicin γ1(I) and phenyl tert-butyl nitrone (PBN): observation of a kinetic isotope effect by an ESR study.
Journal: Chemical communications (Cambridge, England) 20100207
Title: Inspirations, discoveries, and future perspectives in total synthesis.
Journal: The Journal of organic chemistry 20090206
Title: The reactivity of calicheamicin gamma(1)(I) in the minor groove of DNA: the decisive role of the environment.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany) 20070101
Title: Spin-trapping of the p-benzyne intermediates from ten-membered enediyne calicheamicin gamma1I.
Journal: Organic letters 20061123
Title: Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining.
Journal: The Journal of biological chemistry 20041231
Title: Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewisy-positive human carcinoma cells and xenografts.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20040701
Title: Resistance to enediyne antitumor antibiotics by CalC self-sacrifice.
Journal: Science (New York, N.Y.) 20030912
Title: Activation of the DNA-dependent protein kinase by drug-induced and radiation-induced DNA strand breaks.
Journal: Radiation research 20030901
Title: Synthesis of a novel N[bond]O-interglycosidic disaccharide.
Journal: Carbohydrate research 20030812
Title: On the origin of deoxypentoses: evidence to support a glucose progenitor in the biosynthesis of calicheamicin.
Journal: Chembiochem : a European journal of chemical biology 20021104
Title: Thiols alter the partitioning of calicheamicin-induced deoxyribose 4'-oxidation reactions in the absence of DNA radical repair.
Journal: Chemical research in toxicology 20010501
Title: Damelin M, et al. Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions. Clin Cancer Res. 2015 Sep 15;21(18):4165-73
Title: de Vries JF, et al. The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells. Leukemia. 2012 Feb;26(2):255-64
Title: Takeshita A, et al. CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells. Leukemia. 2009 Jul;23(7):1329-36.
